LAQUINIMOD

Drug Teva Pharmaceuticals USA, Inc.
Total Payments
$154,896
Transactions
38
Doctors
17
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $154,896 38 17

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $116,963 20 75.5%
Travel and Lodging $37,256 12 24.1%
Food and Beverage $677.50 6 0.4%

Top Doctors Receiving Payments for LAQUINIMOD

Doctor Specialty Location Total Records
, MD Clinical Cardiac Electrophysiology Wynnewood, PA $32,400 3
, MD Neurology San Francisco, CA $22,997 6
, MD Neurology New York, NY $20,561 5
, MD Neurology Detroit, MI $20,518 6
, MD Neurology Cleveland, OH $18,423 6
, MD Cardiovascular Disease New York, NY $7,000 1
, MD Neurology Rochester, NY $4,200 1
Charles Olanow New York, NY $4,200 1
, MD Neurology Columbus, OH $3,850 1
, MD Neurology Boston, MA $3,850 1
, MD Neurology Aurora, CO $3,850 1
, MD Neurology Philadelphia, PA $3,850 1
, M.D Neurology East Setauket, NY $3,850 1
, MD Neurology Northbrook, IL $3,000 1
, MD Neurological Surgery Grand Rapids, MI $2,300 1
, M.D Epilepsy Northbrook, IL $23.04 1
, MD Rheumatology Chicago, IL $23.04 1

About LAQUINIMOD

LAQUINIMOD is a drug associated with $154,896 in payments to 17 healthcare providers, recorded across 38 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..

Payment data is available from 2017 to 2017. In 2017, $154,896 was paid across 38 transactions to 17 doctors.

The most common payment nature for LAQUINIMOD is "Consulting Fee" ($116,963, 75.5% of total).